Johnson Ali C M, Yabu Julie M, Hanson Sherry, Shah Vallabh O, Zager Richard A
Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA.
Am J Pathol. 2003 Jan;162(1):283-91. doi: 10.1016/S0002-9440(10)63819-9.
Previous studies indicate that acute tubular injury causes free cholesterol (FC) and cholesteryl ester (CE) accumulation within renal cortex/proximal tubules. This study assessed whether similar changes occur with glomerulopathy/nephrotic syndrome, in which high-circulating/filtered lipoprotein levels increase renal cholesterol supply. Potential adaptive changes in cholesterol synthetic/transport proteins were also assessed. Nephrotoxic serum (NTS) or passive Heymann nephritis (PHN) was induced in Sprague-Dawley rats. Renal injury (blood urea nitrogen, proteinuria) was assessed 2 and 7 days (NTS), or 10 and 30 days (PHN) later. FC and CE levels in renal cortex, isolated glomeruli, and proximal tubule segments were determined. SR-B1 (a CE influx protein), ABCA1 (a FC exporter), and HMG CoA reductase protein/mRNA levels were also assessed. FC was minimally elevated in renal cortex (0 to 15%), the majority apparently localizing to proximal tubules. More dramatic CE elevations were found ( approximately 5 to 15x), correlating with the severity of proteinuria at any single time point (r >/= 0.85). Cholesterol increments were associated with decreased SR-B1, increased ABCA1, and increased HMG CoA reductase (HMGCR) protein and its mRNA. Tubule (HK-2) cell culture data indicated that SR-B1 and ABCA1 levels are responsive to cholesterol supply. Experimental nephropathy can increase renal FC, and particularly CE, levels, most notably in proximal tubules. These changes are associated with adaptations in SR-B1 and ABCA1 expression, which are physiologically appropriate changes for a cholesterol overload state. However, HMGCR protein/mRNA increments can also result. These seem to reflect a maladaptive response, potentially contributing to a cell cholesterol overload state.
先前的研究表明,急性肾小管损伤会导致肾皮质/近端小管内游离胆固醇(FC)和胆固醇酯(CE)蓄积。本研究评估了在肾小球病/肾病综合征中是否会出现类似变化,在这些病症中,循环/滤过脂蛋白水平升高会增加肾脏胆固醇供应。同时还评估了胆固醇合成/转运蛋白的潜在适应性变化。在Sprague-Dawley大鼠中诱导产生肾毒性血清(NTS)或被动型Heymann肾炎(PHN)。分别在2天和7天(NTS组)或10天和30天(PHN组)后评估肾损伤情况(血尿素氮、蛋白尿)。测定肾皮质、分离的肾小球和近端小管节段中的FC和CE水平。还评估了SR-B1(一种CE内流蛋白)、ABCA1(一种FC外排蛋白)以及HMG CoA还原酶的蛋白/mRNA水平。肾皮质中的FC仅有轻微升高(0至15%),大部分明显定位于近端小管。发现CE有更显著的升高(约5至15倍),在任何单个时间点都与蛋白尿的严重程度相关(r≥0.85)。胆固醇增加与SR-B1减少、ABCA1增加以及HMG CoA还原酶(HMGCR)蛋白及其mRNA增加有关。肾小管(HK-2)细胞培养数据表明,SR-B1和ABCA1水平对胆固醇供应有反应。实验性肾病可增加肾脏FC水平,尤其是CE水平,最明显的是在近端小管。这些变化与SR-B1和ABCA1表达变化有关,这是胆固醇过载状态下生理上适当的变化。然而,HMGCR蛋白/mRNA也会增加。这似乎反映了一种适应不良的反应,可能导致细胞胆固醇过载状态。